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Aging is associated with lower muscle mass and an increase in body fat. We examined whether creatine monohydrate (CrM)
and conjugated linoleic acid (CLA) could enhance strength gains and improve body composition (i.e., increase fat-free mass
(FFM); decrease body fat) following resistance exercise training in older adults (.65 y). Men (N=19) and women (N=20)
completed six months of resistance exercise training with CrM (5g/d)+CLA (6g/d) or placebo with randomized, double blind,
allocation. Outcomes included: strength and muscular endurance, functional tasks, body composition (DEXA scan), blood tests
(lipids, liver function, CK, glucose, systemic inflammation markers (IL-6, C-reactive protein)), urinary markers of compliance
(creatine/creatinine), oxidative stress (8-OH-2dG, 8-isoP) and bone resorption (N-telopeptides). Exercise training improved all
measurements of functional capacity (P,0.05) and strength (P,0.001), with greater improvement for the CrM+CLA group in
most measurements of muscular endurance, isokinetic knee extension strength, FFM, and lower fat mass (P,0.05). Plasma
creatinine (P,0.05), but not creatinine clearance, increased for CrM+CLA, with no changes in serum CK activity or liver function
tests. Together, this data confirms that supervised resistance exercise training is safe and effective for increasing strength in
older adults and that a combination of CrM and CLA can enhance some of the beneficial effects of training over a six-month
period. Trial Registration. ClinicalTrials.gov NCT00473902
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INTRODUCTION
Human aging is associated with a reduction in muscle mass and
strength that can lead to functional impairment in activities of
daily living. Sarcopenia refers to a reduction in fat free mass (FFM,
.2 SD below normal) that can occur with aging and this leads to
functional impairments in up to 25% of women and men over the
age of 75 y [1–3]. Resistance exercise training is an important
countermeasure for sarcopenia with numerous studies demon-
strating improvements in strength, function, and fat free mass in
older adults [4–8]. Several strategies have been evaluated to
augment the gains in FFM and strength during the course of
resistance exercise training including sex hormone administration
[9] and nutritional supplements [6]. While there is no question
that resistance exercise is the most potent stimulus for the
promotion of strength and FFM gains, adjunctive strategies to
augment these effects may enhance the overall efficacy of strength
training interventions. An increase in body fat occurs with the
aging process. This increase in percentage body fat compounds the
negative effects of the accompanying sarcopenia [10].
Creatine monohydrate (CrM) is a guanidino compound that is
produced endogenously and is naturally occurring in meat
containing products. In addition to its role as a temporal and
spatial energy buffer, CrM supplementation can enhance increases
in fat-free mass (FFM) when given in association with a several
month resistance exercise training program [11–15]. There are
several effects of CrM administration that may enhance resistance
exercise-induced strength gains including activation of myogenic
determination factors [16], enhancement of satellite cell activation
and recruitment [17–19], reduction of amino acid oxidation and
protein breakdown [20], and an increase in myofibrillar mRNA
and protein content [21]. Our group [15], and others [13], have
found that CrM supplementation during a resistance exercise
training program increased FFM gains and some measures of
strength in older adults. By contrast, a few other groups have not
confirmed such results [22,23]. However, in one case there was no
increase in strength following one year of low intensity resistance
exercise training [23], and the other study was cross-sectional in
design [22]. Given some discrepancy in the literature, one aim of
the current study was to evaluate the efficacy of CrM
supplementation as an adjunct to six months of moderate intensity
resistance exercise training on measures of body composition,
functional tasks, and strength in a cohort of older adult men and
women. Given that body fat mass gain is another feature of aging,
and this was not affected by resistance training, with or without
creatine, in our last study [15], we also wanted to evaluate whether
other nutritional compounds could enhance body fat mass losses.
Conjugated linoleic acid (CLA) refers to two naturally occurring
isomers of linoleic acid which are found predominately in dairy
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animals have found a reduction in intra-abdominal fat and
enhanced FFM gains with CLA supplementation [24,26–28].
Other work has reported that CLA-mediated whole body fat loss
in overweight men and women [29–31]; however, the efficacy of
CLA in combination with resistance exercise training in normal
weightyoungmenisequivocal[32].Therehavebeensomeconcerns
that CLA can promote oxidative stress (8-isoprostanes, 8-isoP)
[33,34],andinducehepaticlipidaccumulation [35].Thelattereffect
appears to be isomer specific and is not seen with commercially
available mixtures containing equal proportions of each of the two
major isomers [26,36]. Therefore, a second aim of the study was to
determine whether CLA leads to a reduction in body fat during
resistance exercise training and to evaluate safety issues related to
oxidative stress and hepatic dysfunction in older adults.
In addition to the biomechanical disadvantage resulting from
obesity, body fat accumulation is associated with negative health
outcome indicators including an increase in markers of in-
flammation, oxidative stress, glucose dysregulation, and dyslipide-
mia [37]. The influence of resistance exercise training on markers
of inflammation, blood lipids, and adipokines has rarely been
studied in older adults [38]. Consequently, the final aim of the
study was to evaluate whether resistance exercise training with or
without a CrM+CLA supplementation would favorably alter
markers of inflammation, oxidative stress, blood lipids or
adipokines in older adults.
MATERIALS AND METHODS
Participants
Thirty-nine community dwelling, older adult (65–85 y), men
(n=19) and women (n=20) were recruited from within a 30 km
radius of our research centre (McMaster University) to participate
in a six month resistance exercise training study. None of the
subjects participated in sports training programs or performed
vigorous physical activity more than 3 times per wk, .30 min/d,
in the year prior to the commencement of the study. None of the
subjects had participated in resistance exercise activities in the
preceding two years and most had not done such training. No
participants required the use of assistive devices for mobility.
Recruitment strategies included local newspaper ads, radio
announcements, and flyers distributed to surrounding areas. Each
subject underwent a thorough screening, which included a tele-
phone interview and a medical evaluation. Exclusion criteria
included: evidence of coronary heart disease; congestive heart
disease; uncontrolled hypertension; chronic obstructive pulmonary
disease; diabetes mellitus; renal failure; major orthopedic disabil-
ity; and smoking. All the women were post-menopausal and were
not taking hormone replacement therapy. The study was approved
by the Hamilton Health Sciences Research Ethics Board and the
study has been registered in ClinicalTrials.gov under #
NCT00473902. The protocol for this trial is available as
supporting information; see Protocol S1. Information sessions
were conducted to inform the subjects of the risks and benefits of
participating in a resistance exercise training program and they
provided written consent.
After the initial screening, the subjects were required to perform
a cycle ergometry test to 5 METS (metabolic equivalents) on
a mechanically braked cycle ergometer (Monarch, Varberg,
Sweden). A 12-lead electrocardiogram (ECG, Burdick, Kone
Instruments Corp., Espoo, Finland) was taken prior to and upon
completion of the ergometry test, as part of exclusion criteria to
participate in the resistance exercise training program. Any
participants with abnormal resting ECG’s or a blood pressure of
.160 mmHg systolic and/or 95 mmHg diastolic were not allowed
to complete the screening tests. One subject with questionable post-
exercise exercise ECG changes was referred to a cardiologist for
assessment and wascleared to participateinthe study.A summaryof
the recruitment strategy and allocation is presented in Figure 1.
Nutritional Supplementation
After completion of pre-training testing, subjects were then
randomized to either a combination of CrM and CLA
(CrM+CLA) (5 g CrM (NeotineH)+2 g dextrose/d, Palo Alta,
CA); and 6 g of CLA (CLA-ONEH 45% c9, t11; 45% t10, c12,
Pharmanutrients, Gurnee, IL) or placebo (PL) (7 g dextrose/d+6g
of safflower oil/d) for 24 weeks. The CrM+CLA group consisted
of 11 men and 10 women, while the PL group consisted of 8 men
and 10 women (Table 1). Randomization was done by having
recruited men and women randomly draw from two blocks (one
male and one female) each containing twenty-four shuffled/sealed
envelopes with each block having equal allocation to treatment
(N=12/block) or placebo (N=12/block). After six months of
recruitment and a lack of drop-outs, we closed recruitment with
a total of 19 men and 20 women randomized to the trial. The
flavor and appearance of the supplements were indistinguishable
by the subjects and investigators. Subjects were instructed to
consume their supplements daily and return unused supplements
every month to ensure compliance.
Strength Training
Subjects followed a resistance exercise training program twice per
week for six months, while being supervised in a group
environment for each training session. All participants recorded
each contraction in a log book. Sessions were held on Mondays
and Wednesdays (1200 h–1400 h) or Tuesdays and Thursdays
(1900 h–2100 h) for 24 weeks. Each training session was preceded
by a 5-min aerobic warm-up of spinning on a cycle ergometer or
brisk walking, followed by a brief stretching session. Twelve
exercises were used to train the major muscle groups of the upper
andlowerbodyinacircuit-setsystemusingweighttrainingmachines
(Universal Gym Equipment Inc., Cedar Rapids, Iowa). Subjects
performed 12 repetitions of each exercise including; leg press, chest
press, leg extension, leg flexion, shoulder press, lat pull-down seated
row, calf raise, abdominal crunch, and back extension and 10
repetitions for arm flexion and arm extension. The training protocol
progressed from performing 1 set of each exercise at 50% of their
1RM (repetition maximum) values up to 3 sets of 75% of their 1RM
values over the course of the training period. The 1RM’s were re-
tested every 4 weeks to accommodate any increases in strength by
the subjects and re-adjusted to the new 1RM value.
Testing
Once recruited, each subject was put through three separate visits
for pre- and post-testing. Testing included analyses of functional
and strength measures, body composition, diet records and urine
and blood collection (see below). The same individual completed
all of the strength testing and DEXA scanning to ensure operative
consistency.
Functional Testing
A total of five functional tasks were performed once using
a stopwatch that recorded times to an accuracy 1/100 of a second.
These tasks included; 1. 30 metre walking-subjects walked as fast
and safely as possible for a 30m distance that was marked off with
clear start and stop points; 2. Balance-subjects were timed during
a ‘heel to toe’ tandem gait on a pre-marked 9.14-meter tape line
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for safety. Any step off the line resulted in a one second addition to
the total task time; 3. Sit to stand-subjects performed a series of
consecutive rising and sitting from a sturdy, armless plastic chair
secured against a wall. Starting from a seated position, the numbers
of completed repetitions were recorded over 30 s, with their arms at
their sides or across their chests while performing the task; 4. Chair
rise and walk–starting from a seated position, subjects stood up and
walked as quickly as possible in a predetermined straight line to
a pylon 9.14 m, go around the pylon, and return to their original
seated position; 5. Stair climb–subjects climbed two flights of stairs
(N=14), starting with both feet on the bottom platform and
ascending one step at a time, using a handrail only if insecure.
Strength testing
Isometric ankle dorsiflexion Maximal ankle dorsiflexion was
taken as the highest of three trials of 5 s maximal contractions
using a custom-made isometric device with the ankle joint at 90u,
as previously described [39].
Hand grip strength Hand grip strength was measured using
an isometric dynamometer (JAMARH, Sammons, Bolingbrook,
IL). The grip width was adjusted to hand size and subjects
performed three65 s with a one min rest between each trial.
Isometric and isokinetic knee extension Isometric and
isokinetic (120u/sec) knee extension was measured by using
a dynamometer (Biodex System 3, Biodex Medical Systems,
Shirley, NY). Subjects were positioned into the machine with
the knee flexed at 90u and performed three65 s maximal
voluntary contractions with 30 s rest between each trial at each
speed.
1RM and endurance testing One repetition maximum (1
RM) testing occurred prior to training commencement and post-
training for use as an outcome measurement and to set individual
weight assignments for the training sessions (as above). Subjects
were tested for training intensity adjustments for all 12 exercises
described above, and for outcome variables using four machines:
leg press, chest press, arm flexion, and leg extension (Universal
Gym Equipment Inc., Cedar Rapids, Iowa). Muscle endurance
was also completed at the end of the study using the weight from
Figure 1. Summary of the recruitment strategy and allocation.
doi:10.1371/journal.pone.0000991.g001
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post-training using the original 1RM weight.
Body composition assessment
Body mass and height were measured to the nearest 0.1 kg and
0.5 cm, respectively, using a calibrated electronic scale (Health-O-
meter Pro Series Electronic Scale, Bridgeview, IL) (Table 1). Body
composition was assessed using dual energy x-ray absorptiometry
(DEXA) scan (Hologic QDR 1000W, Waltham, MA) and
a software program for adults (Hologic, V.8.26a). Fat free mass
(FFM), fat mass (FM) and bone mineral density (BMD) of the
entire body, spine, and femur were recorded.
Diet records
To determine dietary composition and consistency during the study,
twoprospective3ddietrecordswerecollectedfromthesubjects1 wk
prior to the start and during the final week of exercise training.
Dietary intake was analyzed using computerized diet analysis
software (Diet Analysis Plus Version 7.0, Thompson Wadsworth,
Canada) for the determination of total energy, % protein (PRO),
carbohydrate (CHO), and fat, alcohol, and calcium intake.
Urine and blood collections
Twenty-four hour urine samples were collected into 4 L containers
before training began, and once again in last week of training. The
samples were kept at 4uC, and delivered to the laboratory within
24 h where the volume was measured and samples were aliquoted
into 5 mL polyethylene tubes and stored at 280uC until
subsequent analysis (see below). All subjects arrived between
0800 h and 0930 h in an overnight post-absorptive state. Blood
was taken from the antecubital vein and drawn into 10 mL
evacuated tubes with heparin used for plasma collection and non-
treated tubes were used to collect serum Samples were centrifuged
at 1200 rpm for 10 min and the serum was aliquoted into 1.5 mL
polyethylene microcentrifuge tubes and stored at 280uC for
subsequent analysis.
Blood and Urine Analyses
Serum glucose, creatine kinase (CK), bilirubin, gamma glutamyl
transferase (GGT), low density lipoprotein (LDL), high density
lipoprotein (HDL), and total cholesterol were each analyzed by the
core laboratory at Hamilton Health Sciences Centre in batches
containing samples from men and women, pre-post training, and
from each of the treatment groups. All other metabolites were
analyzed according to the manufacturer’s guidelines using ELISA-
based assays for leptin (R&D Systems, DLP00, Minneapolis, MN),
C-reactive protein (CRP) (Alpha Diagnostic, U54401841, San
Antonio, TX), adiponectin (R&D Systems, DY1065, Minneapolis,
MN), and interleukin-6 (I-L6) (R&D Systems, HS600B, Minnea-
polis, MN). Insulin concentration was determined using a com-
mercially available radio-immunoassay (Coat-A-Count, TK1N2,
Diagnostics Products, Los Angeles, CA). The HOMA-IR index
was calculated using the equation ([fasting serum insulin (uU/
mL)6fasting plasma glucose (mmol/L)]/22.5).
Urine creatine (Cr) and creatinine (Crn) were analyzed using
high-performance liquid chromatography as described previously
by our group[40]. The creatinine clearance rate was calculated
from the measured serum and urinary creatinine values using the
equation (urine creatinine (mg/dL)6urine vol. (mL/24 h)/
[14406serum creatinine (mg/dL)]). Urinary 8-isoprostanes (8-
isoP, Cayman Chemical, # 516351, Ann Arbour, MI Cayman
Chemical, # 516351, Ann Arbour, MI), 8-hydroxy-2-deoxy-
guanosine (8-OH-2dG, KOG-200SE, Baltimore, MD), and N-
telopeptides (Osteomark, NTx # 504837, Princeton, NJ) were
analyzed by ELISA according to manufacturer’s instructions.
Statistical Analysis
The subject characteristics were analyzed using an unpaired t-test
(age and height). In accordance with NIH guidelines, and given
that sex differences in sarcopenia have been reported [1–3], we
planned our statistical analysis to determine whether or not sex
differences existed. For the main outcome variables of body
composition (FFM and body fat) and strength (knee extension and
handgrip) we first ran a Kolmogorov-Smirnov test and reviewed
the distribution plots to determine whether the data was normally
distributed. In all of these cases the criteria for a normal
distribution were met and our outcome variables were analyzed
using a three-way analysis of variance (ANOVA) with sex as
a between variable (men vs. women), and training (pre vs. post)
and supplement (CrM+CLA vs. placebo) as the repeated measures
variable. A Tukey’s HSD post-hoc analysis for unequal sample sizes
Table 1. Subject Characteristics, Body Composition and Bone Density.
..................................................................................................................................................
Placebo Supplement
MEN (N=8) WOMEN (N=10) MEN (N=11) WOMEN (N=10) Training Effect Sex Effect
Pre Post Pre Post Pre Post Pre Post P value P value
Age (y) 74.866.6 NC 68.364.4 NC 71.865.2 NC 69.563.8 NC NC 0.01
Height (cm) 172.167.4 NC 160.866.8 NC 171.067.4 NC 161.165.2 NC NC 0.00
Weight (kg) 76.768.2 77.267.8 65.3610.5 65.1610.2 81.6611 81.8611.6 66.268.4 65.768 0.98 0.0002
FFM (kg) 55.865.5 57.265.7
{ 41.165.1 41.565.1 58.168.6 60.868.5*
,{ 41.364.4 42.964.7* 0.0001 0.0001
FM (kg) 18.864.4 18.264.2 22.865.7 22.665.9 21.464.9 19.965.9* 23.565.3 21.565.6* 0.0001 0.08
B.M.I. 25.962.7 26.162.5 25.263.0 25.162.9 27.862.1 27.862.1 25.563.1 25.363.0 0.07 0.86
BMD-total 1.2160.09 1.2560.11 1.1360.12 1.1560.13 1.2060.13 1.2360.13 1.0260.09 1.0460.08 0.34 0.0005
BMD-hip 1.0160.09 0.9860.08
{ 0.8660.14 0.8460.13 0.9460.10 0.9260.10
{ 0.8360.10 0.8160.11 0.0001 0.001
BMD-L-spine 1.1260.06 1.1260.07 1.1260.15 1.1160.18 1.1960.14 1.1960.15 0.9460.11 0.9460.09 0.66 0.004
Values are means6standard deviation. NC=no change; FFM=fat free mass; FM=fat mass; BMI=body mass index.
*indicates a significant interaction between training and supplement (see text).
{indicates a significant interaction between men and women in response to training (see text).
doi:10.1371/journal.pone.0000991.t001
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PLoS ONE | www.plosone.org 4 October 2007 | Issue 10 | e991was used to locate pair-wise differences when statistical signifi-
cance was observed. In addition, body composition measures were
further analyzed to blood and urine markers using Pearson R
correlation. Significance was set at P#0.05 (two-tailed). All data
was analyzed using a computerized program (Statistica V5,
Statsoft, Tulsa, OK). Values are reported as mean6standard
deviation (SD).
RESULTS
Subject Characteristics and Body Composition
The men were slightly older, taller, heavier, and had higher FFM
compared to the women (Table 1). Resistance exercise training
increased FFM more for men (+2.0 kg, P,0.001) compared to
women (+1.0 kg, P,0.05), with a significantly greater increase in
FFM for the CrM+CLA group (+2.1 kg, P=0.02) compared to
placebo (+0.9 kg, P=0.06, NS) (Table 1, Figure 2). There was
a significantly greater reduction in fat mass in the CrM+CLA
group following training (21.9 kg, P,0.001) as compared to
placebo (20.4 kg, NS)(Table 1, Figure 2). Total bone mineral
density (BMD) was lower for women and did not change after
training. Hip BMD was lower for women and decreased slightly,
but significantly for men only after training (interaction, P,0.05).
Lumbar BMD was lower for women but did not change in
response to exercise training with or without CrM+CLA (Table 1).
Diet Analysis
Men consumed more energy compared to women (P,0.02), but
there was no effect of training on energy intake, and men on placebo
had lower % fat intake vs. all other groups. There were no other sex,
training, or supplement effects on dietary composition (Table 2).
Muscle Strength Testing
All measures of strength were higher for men compared to women
(Table 3). Every measure of muscle strength (P,0.05 to P,0.001)
increased following exercise training (Table 4). The CrM+CLA
supplement did not further enhance isometric strength measure-
ments after training; however, isokinetic strength increased more
after training for those on supplement vs. placebo (P,0.05).
Women on CrM+CLA showed a greater increase in knee
extension 1RM strength after training as compared to all other
groups (P,0.05). Muscle endurance increased significantly
(P,0.0001) following training (# reps. post-training @ pre-
training 1RM) with the improvements in chest press and arm
flexion showing a greater improvement (P,0.05), with a trend
towards a greater improvement in leg press (P=0.077), for the
CrM+CLA group. There was a three-way interaction (P,0.05)
with women showing a greater improvement in knee extension
endurance after training for the CrM+CLA group (Table 3).
Correlation analysis showed that those with the lowest initial knee
extension strength had the greatest percentage increase in strength
after training (r=20.61, r
2=0.37, P,0.05).
Figure 2. (A) Changes in fat free mass between supplement groups
and sex in response to training. (B) Changes in fat mass between
supplement and sex in response to training. Values are mean-
s6standard deviation. *-indicates a significant difference with
ap ,0.05 (see text).
doi:10.1371/journal.pone.0000991.g002
Table 2. Dietary Analysis.
..................................................................................................................................................
Placebo Supplement
MEN (N=5) WOMEN (N=7) MEN (N=9) WOMEN (N=8) Training Effect Sex Effect
Pre Post Pre Post Pre Post Pre Post P value P value
Intake (kcal/d) 28126914 27776689 19896178 18866356 243561108 240961110 19166466 19746681 0.81 0.02
% PRO 16631 6 621 6 631 7 631 5 631 6 631 7 641 7 62 0.67 0.26
% CHO 60646 1 610 49610 52611 50664 8 654 9 610 5166 0.48 0.14
% FAT 26642 3 643 5 683 3 653 4 663 4 643 5 663 4 64 0.18 0.007
PRO (g/kg)/d 1.360.6 1.460.3 1.460.4 1.260.3 1.160.4 1.160.3 1.260.2 1.360.3 0.81 0.93
%C 2H5OH 3.763.3 6.162.4 3.262.9 3.364.1 4.164.6 5.164 3.863.7 3.163.4 0.21 0.27
Ca
++ 12046387 11626368 7186209 7586158 9136413 7736335 9876462 9516409 0.52 0.17
Values are means6standard deviation. PRO=protein; CHO=carbohydrate; C2H5OH=ethanol; Ca
++=calcium.
doi:10.1371/journal.pone.0000991.t002
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Women had slightly worse balance walk scores and sit to stand
performance compared to men (Table 4). Exercise training
improved all five measures of functional capacity for men and
women with no differential effect of CrM+CLA (Table 4).
Blood Analyses
There were a number of sex differences in the blood measure-
ments with higher leptin, adiponectin, and HDL-C concentrations
in women (P,0.001). Furthermore, women had lower creatinine
and bilirubin concentrations as compared with men. Following
resistance exercise training, there was an increase in CK activity,
and an increase in total and LDL cholesterol (P,0.05), without
a change in LDL/HDL ratio (Table 5). As expected[15], an
increase in serum creatinine was seen following training only in the
CrM+CLA group (P,0.05) (Table 5).
Urine Analyses
Women had higher 8-OH-2dG/creatinine and Cr/Crn ratios and
lower 24 h creatinine compared to men (Table 6). Urinary creatine,
creatinine and Cr/Crn ratios were all higher following training only
in the Cr+CLA supplemented group (Table 6). Neither resistance
training, nor the CrM+CLA supplement, influenced the measured
plasma creatinine clearance. The 8-OH2-dG/creatinine ratio was
lower for both groups following training (Table 6). In contrast, the 8-
isoP/creatinine ratio was higher following training only for the
females in the CrM+CLA group (Table 6). There were no effects of
sex, exercise training or CrM+CLA supplementation on urinary N-
telopeptide excretion (Table 6).
Side Effects
Subjects tolerated the supplementation protocol well, with only
one report of gastrointestinal distress (stomach cramps) on
Table 3. Muscle Strength Tests.
..................................................................................................................................................
Placebo Supplement
MEN (N=8) WOMEN (N=10) MEN (N=10) WOMEN (N=10) Training Effect Sex Effect
Pre Post Pre Post Pre Post Pre Post P value P value
Isometric
Knee Ext.(Nm) 133.9637.3 152.0644.7 78.6612.6 96.0620.2 135.8637.4 151.4652.4 86.0614.3 105.6617.8 0.0001 0.0001
Dorsiflexion(Nm) 56.7614.9 55.9614.4 35.564.6 37.365.2 48.8610.9 54.7612.7 30.465.2 34.167.6 0.03 0.0001
Jamar (kg) 39664 2 662 5 642 7 643 9 674 3 672 7 653 0 64 0.0001 0.0001
Isokinetic
Knee 120 deg/sec 93.1626.7 101.3623.4 53.2620.2 64.769.2 88.2627.2 108.2626.2* 57.7616.4 68.0615. 5* 0.0001 0.0001
1 Repetition Maximum (lb)
Chest Press 98623 136616 60612 9169 104635 146638 53678 9 615 0.0001 0.0001
Arm Flexion 64617 104623 32695 7 611 76635 115636 29676 1 616 0.0001 0.0001
Leg Press 205655 269652 137633 187654 215659 295674 123622 200631 0.0002 0.0001
Knee Extension 106620 158631 81627 109613 117639 163644 64616 113618
{ 0.0001 0.0001
Endurance (lb)
Chest Press 1601 7 611 1601 8 661 602 2 610* 1603 2 611* 0.0001 0.12
Arm Flexion 1601 6 671 601 5 691 602 1 612* 1602 5 69* 0.0001 0.56
Leg Press 1602 1 616 1602 7 612 1602 7 613 1604 6 627 0.0001 0.07
Knee Extension 1601 7 681 601 0 621 601 4 641 601 7 66
{ 0.0001 0.38
Values are means6standard deviation. RM=repetition maximum.
*indicates a significant interaction between training and supplement (see text).
{indicates a significant interaction between training, supplement and gender (see text).
doi:10.1371/journal.pone.0000991.t003
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Table 4. Functional Tests.
..................................................................................................................................................
Placebo Supplement
MEN (N=8) WOMEN (N=10) MEN (N=11) WOMEN (N=10) Training Effect Sex Effect
Pre Post Pre Post Pre Post Pre Post P value P value
Sit and Stand (#)1 3 621 6 611 0 621 4 641 2 621 5 631 1 631 3 62 0.0001 0.0005
Timed Stairs (sec) 6.860.6 6.961.5 8.761.7 8.161.6 8.161.3 7.761.5 7.860.9 6.960.9 0.004 0.24
Walk Test (sec) 14.862.7 13.762.1 17.562.5 16.162.4 17.362.6 16.663.5 16.862.0 15.161.2 0.0001 0.34
Chair and Walk (sec) 13.461.7 11.462.3 15.062.4 13.362.2 14.562.4 13.763.1 14.362.1 12.661.3 0.0001 0.08
Balance Walk (sec) 23.468.5 22.369.0 3366.1 28.167.6 32.6611.4 27.468.1 31.968 25.367.8 0.04 0.04
Values are means6standard deviation. Sec=seconds; #=number completed.
doi:10.1371/journal.pone.0000991.t004
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PLoS ONE | www.plosone.org 6 October 2007 | Issue 10 | e991CrM+CLA but this did not lead to discontinuance of the study.
Furthermore, there were no reports of muscular cramping or any
other subjective symptoms during the study. Subjects variably
reported delayed onset muscle soreness yet none developed any
musculoskeletal injuries that required them to discontinue the
study. Two individuals complained of anterior knee pain during
the knee extension exercises that required a slower increase in the
intensity of the training sessions. No individual dropped out due to
musculoskeletal injuries.
DISCUSSION
We found that six months of twice weekly, supervised, resistance
exercise training robustly improved muscle strength and functional
capacity in community dwelling older adults. Significant improve-
ments in body composition (increased FFM and lower fat mass)
were seen following resistance exercise training only for the
CrM+CLA intervention group. There were several measurements
of strength that were higher after training on the CrM+CLA arm
of the study, particularly muscular endurance. Other than
a reduction in a marker of DNA oxidative stress (8-OH-2-dG)
there were no other blood or urine markers that showed changes
that would be consistent with a reduction in risk for the metabolic
syndrome following resistance exercise training. No adverse affects
were noted clinically or serologically, and markers of inflammation
(CRP and IL-6), adipocytokines (leptin and adiponectin), and
glucose homeostasis (fasting glucose and HOMA-IR index)
showed no effect from training or supplementation. Total
cholesterol and LDL increased following training for all groups,
but the LDL/HDL ratio did not change.
Previous findings of an augmented increase in FFM following
resistance exercise training with CrM administration in older
adults [13,15], were confirmed in the current study. We have also
previously reported that older adults show a significant increase in
total muscle creatine following four months of CrM supplemen-
tation at the same dose as used in the current study [15]. An
increase in satellite cell number occurs in older adults in response to
resistance exercise training [41,42], and CrM has recently been
shown to enhance satellite cell activation during resistance exercise
training in younger men [17]. Together, the aforementioned data
suggest that CrM may enhance the resistance exercise induced
activation ofsatellite cells and contribute tothe increase inFFMseen
in the current study. It is not possible to determine what proportion
oftheincrease inFFM was due tothe CrM and what may havebeen
due to the CLA component of the supplement. It is likely that much
ofthe increaseinFFM wasdue to CrMgiven that the potentiationof
the FFM gains seen in the current study were quantitatively similar
to those previously reported by our group [15], and others [13],
using CrM only.Furthermore, CLA supplementation alonedoes not
appear to enhance FFM gains in young men completing a resistance
exercise program [32]. The molecular mechanism(s) behind the
observed enhancement of the FFM with CrM were not evaluated in
the current study and may have included an increase in satellite cell
recruitment[17,19],lowerproteinbreakdownandoxidation[20],or
increased myofibrillar protein accretion [21]. Given that the
progression of the exercise program was set as a parameter for each
participant, that we recorded every repetition and weight lifted
during the entire six months of training, and that the final 1 RM
values were the same for all groups (aside from slightly greater
increases in2 of10 exercises for thewomenon supplement),the total
‘‘volume’’ of training over the six months was virtually identical
between supplemented and non-supplemented groups (especially for
men). Consequently, some of the improvements in mass and
muscular endurance must have been due to molecular or
physiological alterations induced by the supplement per se and not
due to a higher total volume of exercise over the six months.
In addition to a greater increase in FFM after training with the
CrM+CLA supplement, we found that several measurements of
strength increased to a greater degree in the supplemented groups.
In a previous study we found that isometric knee extension
strength increased for men and women, and dorsiflexion strength
increased only for men following four months of resistance exercise
Table 5. Blood Analysis.
..................................................................................................................................................
Placebo Supplement
MEN (N=8) WOMEN (N=10) MEN (N=11) WOMEN (N=10) Training Effect Sex Effect
Pre Post Pre Post Pre Post Pre Post P value P value
Glucose (mmol/L) 4.860.5 4.86 0.5 4.660.5 4.860.8 5.060.6 4.96 1.70 4.960.5 4.760.6 0.89 0.63
HOMA-IR 1.5361.01 1.3660.66 0.7660.59 1.2861.46 1.5461.36 1.2360.99 1.4361.01 0.9460.35 0.50 0.34
CK (mmol/L) 90.1626.9 113.8629.8 103.3631.7 120.3638.6 114.8650.1 180.36120.5 146.06153.3 187.76181.7 0.0001 0.78
Bili (mmol/L) 9.362.9 10.662.3 7.562.2 7.561.5 10.563.9 11.666.0 7.563.0 7.862.4 0.17 0.02
GGT (mmol/L) 26.467.9 25.564.9 27.3617.0 26.6612.4 30.5622.5 27.8622.3 21.2612.8 22.665.9 0.90 0.90
Crn (mmol/L) 87610 86667 1 610 70614 90619 114625* 71611 80617* 0.0001 0.0001
LDL (mmol/L) 3.0360.56 3.3360.75 3.2761.08 3.4661.19 3.1460.45 3.3360.54 3.2060.96 3.5460.85 0.002 0.83
HDL (mmol/L) 1.5760.32 1.6360.39 2.0760.45 2.2260.59 1.3260.28 1.3460.21 1.8260.31 1.8360.37 0.09 0.0001
Chol (mmol/L) 5.3560.57 5.6860.85 5.9661.16 6.3261.38 5.3760.51 5.5460.72 5.6861.09 6.1361.00 0.0007 0.23
LDL/HDL (mmol/L) 2.0260.59 2.1960.81 1.6560.68 1.6260.62 2.4760.62 2.5460.59 1.8460.79 2.0260.72 0.097 0.018
Leptin (ng/mL) 4.5461.87 4.8462.26 16.0610.26 15.3369.61 4.8462.47 4.3863.70 16.21612.74 16.95615.97 0.97 0.0003
CRP (mg/L) 2.9863.24 1.8561.05 3.6563.62 3.8064.25 2.5663.12 3.7964.33 3.3163.5 5.1263.47 0.44 0.23
Adipon. (mg/L) 9.6564.33 10.3263.96 17.1267.54 16.4766.33 7.1864.39 6.4863.19 12.8965.84 13.7267.1 0.96 0.0003
IL-6 (pg/mL) 2.3863.2 2.3362.21 3.9163.03 4.0663.05 5.4863.08 7.364.47 1.8161.46 2.046.82 0.10 0.61
Values are means6standard deviation. HOMA-IR=homeostasis model assessment of insulin resistance; CK=creatine kinase; billi=bilirubin; GGT=gamma glutamyl
transferase; LDL=low density lipoprotein; HDL=high density lipoprotein; Chol=total cholesterol; CRP=C-reactive protein; Adipon.=adiponectin; IL-6=interleukin -6.
*indicates a significant interaction between training and supplement (see text).
doi:10.1371/journal.pone.0000991.t005
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PLoS ONE | www.plosone.org 7 October 2007 | Issue 10 | e991training (3 x/wk) [15]. In spite of men showing higher strength
values for every outcome measurement in the current study, most
measurements of strength improved similarly for men and women.
Knee extension strength was the only strength outcome that
showed a sex difference with greater increases for women on
CrM+CLA after training compared to all other groups. Since we
found that those with the lowest initial strength showed the
greatest percentage improvements in strength (r=20.61), it may
be that this latter finding was reflective of the lower initial strength
in the women randomized to CrM+CLA and not a true effect of
the supplement per se. Nevertheless, this latter finding is of
significant clinical relevance because older adults with very low
levels of strength are at the greatest risk of falling [43,44], and
therefore, it is this group that would stand to gain the most from
a resistance exercise training program.
A novel finding in the current study was the robust reduction in
the fat mass seen after resistance training in the CrM+CLA group.
We feel that this effect was primarily due to the CLA component for
a number of reasons. Firstly, almost every study looking at the effects
of CrM alone during resistance exercise training did not find any
effect on fat mass [12,13,15]. Secondly, studies in overweight
humans have found a lower fat mass after CLA supplementation at
about the same dose as used inthe current study [29–31,45]. Finally,
there is strong biological rationale for a reduction in body fat
secondary to CLA supplementation. CLA has consistently been
shown to lower body fat in animals, likely by increasing PPARa,a n d
SREBP1 in adipocytes and inducing transcription of components of
b-oxidation [26,46,47]. CLA has also recently demonstrated an
ability to normalize impaired glucose tolerance and improve
hyperinsulinemia in a pre-diabetic animal model. It is not clear
whatthedistributionofbodyfatwasinthecurrentstudybecauseCT
orMRIscanningwasnotusedtoquantifyintra-abdominalfatstores.
Given that abdominal obesity and intra abdominal fat are greater
metabolic risk factors for the metabolic syndrome complications
[48,49], it will be important in future studies to evaluate these
variables in response to training and CLA.
A large number of studies have looked at the beneficial effects of
endurance exercise training on serum markers of metabolic risk
including; inflammation (CRP, IL-6, TNF), dysglycemia (HOMA-
IR, euglycemic clamps, fasting glucose, hemoglobin A1C),
oxidative stress (8-isoP, oxidized LDL), or adipocytokines (leptin,
adiponectin) [38,50–56]. Fewer studies have examined the
potential for resistance exercise to favorably alter serum variables
associated with higher risk of metabolic disease complications
[38,57,58]. Two studies have found that resistance exercise
reduced hemoglobin A1C in older adults with type 2 diabetes
[57,58]. We did not find any evidence of a beneficial influence of
training or CrM+CLA on HOMA-IR or fasting blood glucose in
the current study. However, this could be due to the fact that none
of our older adults had type 2 diabetes, and therefore, the potential
for improvement was less. There has been some concern that CLA
administration (either the c9, t11 or t10, c12 isomer) could lead to
an increase in markers of oxidative stress and that this was
responsible for an increase in insulin resistance [33,59]. In
contrast, CLA supplements containing combinations of the two
major isomers taken together did not show the same negative
effects on oxidative stress or systemic inflammation [33]. We found
that the women who took the CrM+CLA supplement had higher
concentrations of 8-isoprostanes as compared with all other
groups. Given that neither this group nor the others showed any
evidence of oxidative stress using the DNA marker, renders the
biological significance unclear. Our data suggests that a combina-
tion of CLA isomers taken during a resistance exercise training
program does not negatively influence markers of inflammation
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PLoS ONE | www.plosone.org 8 October 2007 | Issue 10 | e991(CRP, IL-6) or dysglycemia (HOMA-IR, fasting glucose) or
markers of DNA oxidative damage (8-OH-2dG).
The results of the current study confirmed our earlier finding
that resistance exercise training was associated with a reduction in
a marker of DNA oxidative stress (8-OH-2dG) [60]. Our previous
work using a similar training stimulus indicated that this effect was
due to a training induced induction of the anti-oxidant enzymes,
catalase and Cu/Zn superoxide dismutase [61]. In contrast, there
was no beneficial effect consequent to the training program with
respect to oxidative stress measured using the 8-isoprostanes, and
the women on CrM+CLA showed an increase in 8-isoprostanes
after training. One study found that acute resistance exercise did
not alter 8-isoprostanes in blood [62], and another found no
difference in 8-isoprostanes in trained athletes compared to
sedentary controls [63]. Our data is in general agreement with
the latter two studies in that three of our groups showed no
significant influence of training on 24 h 8-isoprostane excretion.
The biological significance of the increase in 8-isoprostanes for
women on CrM+CLA is unclear as is the discrepancy between the
8-OH2dG and the 8-isoprostane results. Our data showing that
resistance exercise training leads to an increase in anti-oxidant
enzyme activity in older adults renders the 8-OH-2dG results
more biologically plausible.
Several studies have found that endurance exercise can
favorably improve blood lipid profiles in a direction associated
with a lower risk of cardiovascular disease risk (Q LDL, q HDL)
[64], while others have found that up to six months of endurance
training had no effect on LDL or total cholesterol values [65,66].
The evidence for resistance exercise to improve blood lipid profiles is
less consistent or robust [67]. Other factors such as hormonal status
in women can influence the response of LDL to an endurance
exercise stimulus with increases only seen for women taking
hormone replacement [68]. Another group found that genotype
influenced the HDL response to 6 months of endurance exercise
training where increases were only seen for a specific genotype in the
cholesteryl ester transfer protein allele [65]. In the current study
there were significant increases seen for both LDL and total
cholesterol in both sexes and in both groups after six months of
training, yet the ratio of LDL/HDL was not altered. Given that the
trial was six months in duration and we did not have a non-exercised
control group, it is possible that this minor alteration represented
a normal aging phenomenon. Whether or not longer term
supplementation with CLA [29], and/or a longer duration of
training would have beneficial effects on lipid profiles is unclear.
Resistance training has been shown to have variable and
inconsistent effect upon bone turnover and bone density. Some
have shown improvements in markers of bone turnover within
16 weeks of high intensity weight training [69], while others have
observed improvements in bone mineral density and osteocalcin
after 6 months of high intensity weight training [70], in older
adults. In contrast, others have reported no changes in markers of
bone turnover following 12 weeks of resistance training in older
women [71]. The lack of consistency in the response of bone to
resistance training likely results from a number of different factors
including differences in training intensity and duration and subject
population factors such as aging. Given that the osteogenic
response to weight training appears to be blunted in older adults
[72], and that changes in bone mineral density in response to any
intervention take from 6 months to a year to detect [70], it is
possible that a higher intensity or a longer duration may have
favorably influenced bone mass and markers in the current study.
Creatine monohydrate has been shown to stimulate metabolic
activity, differentiation and mineralization in osteoblast-like cell
cultures [73]. Two groups have found lower N-telopeptide
excretion (a marker of bone catabolism) in boys and young men
with muscular dystrophy following CrM supplementation [74,75].
In contrast, we did not find any effect of four months of resistance
exercise training with or without CrM supplementation on bone
mineral density or osteocalcin in older men and women [15]. In
the current study we did not find any beneficial effects of either the
CrM+CLA supplement or resistance training on markers of bone
turnover or bone density measurements.
No participants experienced side effects from the training or the
supplementation that led to discontinuance of the study. These
findings concur with other studies using progressive weight
training in older adults [6,7,13,76], and those with obesity and
type 2 diabetes [38,57,58]. We did start with a fairly modest initial
intensity of 50% of the 1 RM, which we have found to be safe in
the training of older adults in the past [15]. There was a slight
increase in serum CK activity with resistance training; however,
this was not associated with any pigmenturia, muscle cramps and
in no case was the CK elevation greater than 400 U/L
(N,220 U/L), and there were no differential increased in CK
activity with the CrM+CLA supplement. Given that creatine is
converted non-enzymatically to creatinine, we did find the
expected and previously reported [15], increase in serum
creatinine for the groups taking the supplement containing CrM.
As with our previous study [15], we did not find any influence on
measured creatinine clearance, which we took to indicate that
there were no negative effects on renal function. Furthermore,
others have not found any evidence of renal dysfunction with short
and long-term CrM administration [15,77–79].
In conclusion, we have confirmed the beneficial effects of
resistance exercise training on increasing FFM, strength, and
function in older adults and have added novel data showing that
a combination of CrM+CLA lead to greater increases in FFM and
losses of fat mass. Furthermore, those on the supplement showed
greater muscular endurance and no evidence of clinical or
serological side effects. Whether such changes are maintained in
the longer term is unclear at this point.
SUPPORTING INFORMATION
Protocol S1
Found at: doi:10.1371/journal.pone.0000991.s001 (0.14 MB
DOC)
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